Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep216 | Calcium and Bone | ECE2023

Brown tumor revealing primary hyperparathyroidism

Alami Hassani Chaymaa , Lahousssaine Abainou , Idrissi Ayoub , Elhadri Sanae , Meftah Azzelarab , Baizri Hicham

Introduction: Hyperparathyroidism is a frequent endocrinopathy, often diagnosed in the stage of asymptomatic hypercalcemia. The revelation by a bone or renal complication has become increasingly rare dominated by osteoporosis and brown tumors giving a blown aspect of the cortices exposing to pathological fractures. We report 2 cases of primary hyperparathyroidism revealed by a brown tumor and pathological fracture.Observation 1: This is a 52 year old fem...

ea0090ep959 | Thyroid | ECE2023

Anasarca state with exceptional localization revealing a deep hypothyroidism

Alami Hassani Chaymaa , Idrissi Ayoub , Lahousssaine Abainou , Elhadri Sanae , Meftah Azzelarab , Baizri Hicham

Introduction: Hypothyroidism-related anasarca is due to the capillary permeability disorders associated with hypothyroidism. It is a rare mode of revelation especially when associated with ascites, which is an exceptional localization. We report the case of a deep hypothyroidism revealed by an ascites of great abundance. Observation: Our patient is 73 years old with a history of 2 daughters followed for Hashimoto’s thyroiditis. He consults for abdom...

ea0090ep1075 | Thyroid | ECE2023

A vesicular carcinoma of the thyroid on Graves’ disease: a rare association

Alami Hassani Chaymaa , Idrissi Ayoub , Lahousssaine Abainou , Elhadri Sanae , Meftah Azzelarab , Baizri Hicham

Introduction: The occurrence of vesicular carcinoma in Graves’ disease is exceptional. It is most often a papillary carcinoma rarely vesicular. We report the case of a vesicular carcinoma discovered at the anatomopathological study of a total thyroidectomy in a patient followed for Graves’ disease.Observation: This is a 61-year-old female patient with type 2 diabetes, on SGLT2 inhibitor. There isn’t any family history of thyroid cancer or ...

ea0070aep77 | Adrenal and Cardiovascular Endocrinology | ECE2020

Primary aldosteronism : Study of 09 cases

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Introduction: Primary aldosteronism (PHA), also known as primary hyperaldosteronism or Conn’s syndrome, refers to the excess production of the hormone aldosterone from the adrenal glands.Study objectives: To show clinical, biochemical, and morphological data of 09 patients with primary hyperaldosteronism as well as the therapeutic choice for each patientMehtods: it is aretrospective and descriptive study of 09 cases with prim...

ea0070ep163 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Bariatric surgery : About 10 cases

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Meftah Azelarab , Barni Rachid El , Youssef Qamouss , Baizri Hicham

Introduction: Bariatric surgery is the treatment which has shown the most important effectiveness in terms of weight reduction, improvement of co morbidities, quality of life and mortality on the long term, in the case of massive obesity and obesity associated with co–morbidities. The purposes of our study: clarify the place of bariatric surgery in the treatment of obesity, define the criteria of selections of patients.Material and Methods: It&#821...

ea0070ep191 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

The serological prevalence of celiac disease (cd) in patients with type 1 diabetes (dt1)

Lahousssaine Abainou , Ayoub Idrissi , El Jadi Hamza , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Introduction: Celiac disease is an autoimmune disease triggered by gluten frequently associated with other autoimmune diseases, among which is type 1 diabetes first.Objectives: The objectives of our study are:– To determine the serological prevalence of celiac disease (CD) in patients with type 1 diabetes (DT1)– Compare the clinical and biological characteristics of seropositive and seronegative p...

ea0070ep521 | Thyroid | ECE2020

Radioiodine therapy and Graves’ disease

Lahousssaine Abainou , El Jadi Hamza , Idrissi Ayoub , Elhadri Sanae , Miftah Azelarab , Baizri Hicham

Used for the first time in 1941 in the United States by Hertz and Roberts for the treatment of hyperthyroidism in Grave’s Disease, radioactive active therapy (RAI) has been able to gain its place within the already existing therapeutic arsenal by being efficient, easy to use and minimally invasive. Our work is a retrospective study of 46 patients collected at the Department of Endocrinology, over a period of 7 years and half from January 1, 2011 to June 30, 2018. The pur...